ARTICLE | Company News
WuXi Biologics to manufacture NBE’s ADC for clinical trials
April 11, 2019 8:55 PM UTC
WuXi Biologics will manufacture NBE-Therapeutics’ lead antibody-drug conjugate, NBE-002, for use in clinical trials worldwide.
NBE-Therapeutics AG (Basel, Switzerland) plans to begin trials of the ADC in mid-2020...
BCIQ Target Profiles